Rhythma Kaul
Hindustan Times
New Delhi, DL, India
Contact Rhythma
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Rhythma:
India records first case of BA.4 variant in Hyderabad
The first possible case of an infection with the BA → Read More
Covishield, Covaxin get conditional market nod
The approval is an upgrade from the emergency use authorisation and largely represents a regulatory endorsement of the safety doses. → Read More
Roche India launches Covid-19 at-home testing kit
By following instructions, individuals can perform tests at home without special training or the supervision of healthcare workers and expect results in 15 minutes → Read More
Senior citizens will not need doctor’s certificate for precautionary shot: Centre
However, people above 60 years of age should still take a doctor’s advice before applying for a third dose, the Union health ministry has said. → Read More
NFHS survey: Health insurance coverage rises, officials credit Ayushman Bharat
coverage in the rural sector is higher at 42.4%, and urban areas, 38.1% | Latest News India → Read More
Government expert group could recommend inclusion of ZyCoV-D in India vaccination drive
ZyCoV-D, the Covid-19 vaccine developed by Zydus Cadila in partnership with the Department of Biotechnology, is likely to be included in the national immunisation programme as a government expert group is expected to recommend its inclusion next week, said an official aware of the matter | Latest News India → Read More
Covid vaccine for children in India by September, says ICMR-NIV director
“Hopefully, the results (of the trials) are going to be available very soon. The results will be presented to the regulators. So, by September or just after it, we may have Covid-19 vaccines for children,” Priya Abraham said in an interview to India Science, an OTT channel of the science and technology department | Latest News India → Read More
Vaccines reduce hospitalisation, death due to Covid: ICMR study
The nationwide study during the peak of second wave between April and June 2021, is likely the largest and first nation-wide study of post-vaccination breakthrough infections from India with 677 clinical samples | Latest News India → Read More
Strong immune response in mixed jab: Studies
New Delhi: A second shot of a messengerRNA (mRNA) based Coronavirus disease (Covid-19) vaccine administered to those vaccinated with first dose of the Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccine induces a strong immune response, researchers have found in two separate studies , one of which was released on Thursday → Read More
Moderna’s Covid vaccine approved for use in India
NEW DELHI India on Tuesday approved the import of US pharmaceutical major Moderna’s mRNA technology-based coronavirus disease (Covid-19) vaccine, paving the way for the entry of the first international vaccine against the infectious disease into the country | Latest News India → Read More
India administers record 8.6mn doses on Day 1 of universal Covid vaccine drive
In all, close to 300 million vaccine doses have been administered across the country since the national Covid-19 immunisation drive began in the country on January 16, 2021 | Latest News India → Read More
Over 8 million shots on Day 1 of new drive
On Monday, almost every state in the country vaccinated the most people ever covered in one day until now, but some warned that they may not be able to keep up the pace unless supplies were replenished. → Read More
Schools may not open any time soon, says govt
NEW DELHI Schools will only be reopened after adequate consultation as scientific data and evidence from other countries suggest that more information is required before allowing children back into classrooms during a pandemic, Niti Aayog member (health) VK Paul said at a Union health ministry briefing on Friday | Latest News India → Read More
Covaxin phase 3 trial results to be out in July: Bharat Biotech
The Bharat Biotech shot, Covaxin, is one of the three vaccines currently approved in India for emergency use owing to the pandemic. | Latest News India → Read More
Centre issues advisory for rational use of Remdesivir
India has allowed use of remdesivir only in select moderate to severe hospitalised Covid-19 patients on supplemental oxygen, as it is a reserve drug approved by the drugs controller general of India under the emergency use authorisation only. → Read More
28,252 cases of black fungus logged during 2nd wave: Govt
India has reported about 28,252 cases of mucormycosis, a fungal infection, following the second wave of Covid-19, Union health minister Harsh Vardhan said on Monday while chairing the 28th meeting of the group of ministers (GoM) on the pandemic | Latest News India → Read More
NPPA caps trade margin on oxygen concentrators
Based on the notified trade margin, NPPA has instructed the manufacturers and importers to report revised MRP within three days. Revised MRPs will be informed in public domain within a week by NPPA | Latest News India → Read More
India’s first indigenous home-based rapid Covid test launched commercially
According to the company, the product should be available in retail within 2-3 days. The company plans to make the products available on the government e-marketplace (GEM) → Read More
Eli Lilly receives emergency-use approval for antibody drugs to treat Covid-19
Bamlanivimab and etesevimab together can be administered via injection in a restricted manner to adults and paediatric patients (12 years and older, weighing at least 40kg) in an emergency | Latest News India → Read More
Exploring possibility for Covid vaccine imports to India: Cipla
The statement came amid reports that Cipla was seeking fast-track approvals to bring Moderna’s single-dose Covid-19 booster vaccine into India expeditiously, and that it has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty | Latest News India → Read More